Order Waives Restrictions on Pharmacists Independently Initiating and Furnishing Paxlovid to Individual Patients

On July 6, the Food and Drug Administration amended the Emergency Use Authorization (EUA) for Paxlovid, an orally administered COVID-19 therapeutic drug. The amended EUA expressly permits licensed pharmacists to independently order Paxlovid for individual patients under certain conditions.